Invivyd, Inc. (IVVD) vs Niagen Bioscience, Inc. (NAGE)
- Invivyd, Inc. IVVD 0.62 −7.46%
- Niagen Bioscience, Inc. NAGE 2.49 −3.49%
Invivyd, Inc. and Niagen Bioscience, Inc. are both Biotechnology companies. Invivyd, Inc. and Niagen Bioscience, Inc. are of similar size ($204.2M and $197.1M). Invivyd, Inc. has negative trailing earnings, so its P/E is not meaningful; Niagen Bioscience, Inc. trades at 12.5×. Invivyd, Inc. grew revenue faster over the last twelve months: 26.3% against 11.0%. Niagen Bioscience, Inc. has the higher net margin (12.4% vs −183.9%) and the higher return on invested capital (42.0% vs −334.9%). Across the 16 metrics below, Niagen Bioscience, Inc. leads on 12 and Invivyd, Inc. on 4.
Valuation
Profitability
| Metric | IVVD | NAGE | Biotechnology median |
|---|---|---|---|
| Gross margin | 92.23% | 64.24% | 65.16% |
| Operating margin | (192.81%) | 8.21% | 0.00% |
| Net margin | (183.90%) | 12.39% | 0.00% |
| Free cash flow margin | (187.88%) | 8.89% | 0.00% |
| Return on equity | (95.89%) | 21.80% | (56.36%) |
| Return on assets | (69.69%) | 16.14% | (48.04%) |
| Return on invested capital | (334.92%) | 41.95% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack